PVLA
Palvella Therapeutics, Inc
NASDAQ: PVLA · HEALTHCARE · BIOTECHNOLOGY
$130.17
+0.54% today
Updated 2026-05-06
Market cap
$1.82B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.70
Dividend yield
—
52W range
$20 – $151
Volume
0.3M
Palvella Therapeutics, Inc (PVLA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-45.90M | $-7.66M | $-14.84M | $-13.70M | $-10.84M | $-25.01M |
| Capital expenditures | $2.73M | $949000.00 | $1.04M | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | — | $427000.00 | $603000.00 | $830000.00 | $6.40M |
| Free cash flow | $-48.62M | $-8.61M | $-15.88M | $-13.70M | $-10.84M | $-25.01M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |